2025

Bellvitge leads the first clinical trial to evaluate antifibrotic benefit in patients with post-COVID fibrosis

The study confirms the improvement in severe lung affectation after COVID-19 thanks to the combination of pirfenidone and corticosteroids.

Bellvitge leads the first clinical trial to evaluate antifibrotic benefit in patients with post-COVID fibrosis Read More »

IDIBELL and Bellvitge Hospital receive funding to improve tolerance in kidney transplants

IDIBELL and the Bellvitge Hospital will promote a new project to improve immune tolerance in kidney transplant patients and reduce the risk of rejection.

IDIBELL and Bellvitge Hospital receive funding to improve tolerance in kidney transplants Read More »

Cognitive impairment in lung cancer, an undervalued disorder with new approaches and treatment perspectives

31% of patients already had symptoms of cognitive impairment at the time of lung cancer diagnosis, underscoring the importance of monitoring this disorder to improve patients’ quality of life.

Cognitive impairment in lung cancer, an undervalued disorder with new approaches and treatment perspectives Read More »

Science and the street meet in Sinergia, the IDIBELL open day

This past Saturday, June 14, science coloured the Bellvitge neighbourhood thanks to Sinergia, the open doors of IDIBELL and the Bellvitge health campus with the support of the City Council of L’Hospitalet del Llobregat. It did so with workshops, organised activities, games, and music to get closer to the residents of the city, inviting them

Science and the street meet in Sinergia, the IDIBELL open day Read More »

Scroll to Top